MarketCapTrends
AMGN

Amgen Inc. (AMGN)

NASDAQ · Healthcare

Amgen Inc. annual/quarterly long term debt history from 2009 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • Amgen Inc. long term debt for the quarter ending December 31, 2025 were 54.60B, a 9.14% decrease year-over-year.
  • Amgen Inc. long term debt for 2025 were 54.60B, a 9.14% decrease from 2024.
  • Amgen Inc. long term debt for 2024 were 60.10B, a 6.99% decrease from 2023.
  • Amgen Inc. long term debt for 2023 were 64.61B, a 65.91% increase from 2022.
  • Amgen Inc. long term debt for 2022 were 38.95B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Amgen Inc. Annual Long Term Debt (Millions of US $)
2025$54,604
2024$60,099
2023$64,613
2022$38,945
2021$33,309
2020$32,986
2019$29,903
2018$33,929
2017$35,342
2016$34,596
2015$31,429
2014$30,715
2013$32,128
2012$26,529
2011$21,428
Amgen Inc. Quarterly Long Term Debt (Millions of US $)
2025-12-31$54,604
2024-12-31$60,099
2023-12-31$64,613
2022-12-31$38,945
2021-12-31$33,309
2020-12-31$32,986
2019-12-31$29,903
2018-12-31$33,929
2017-12-31$35,342
2016-12-31$34,596
2015-12-31$31,429
2014-12-31$30,715
2013-12-31$32,128
2012-12-31$26,529
2011-12-31$21,428
2010-12-31$13,362
2009-12-31$10,601

Amgen Inc. Long Term Debt — FAQ

Amgen Inc. (AMGN) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AMGN's long term debt history?

The chart and table above show Amgen Inc.'s long term debt by year and by quarter, including the growth rate.